Millennium Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-37,703
Closed -$15.8K 6315
2025
Q4
$15.8K Sell
37,703
-343,273
-90% -$182K ﹤0.01% 5834
2025
Q3
$257K Buy
380,976
+16,829
+5% +$9.07K ﹤0.01% 5420
2025
Q2
$197K Sell
364,147
-807,945
-69% -$480K ﹤0.01% 5367
2025
Q1
$769K Sell
1,172,092
-1,567,574
-57% -$1.66M ﹤0.01% 4545
2024
Q4
$2.79M Buy
2,739,666
+828,337
+43% +$1.51M ﹤0.01% 3368
2024
Q3
$1.66M Sell
1,911,329
-496,868
-21% -$364K ﹤0.01% 3879
2024
Q2
$863K Buy
2,408,197
+1,303,320
+118% +$704K ﹤0.01% 4201
2024
Q1
$740K Sell
1,104,877
-17,722
-2% -$12.9K ﹤0.01% 4543
2023
Q4
$610K Buy
1,122,599
+746,166
+198% +$344K ﹤0.01% 4522
2023
Q3
$226K Sell
376,433
-541,021
-59% -$579K ﹤0.01% 5057
2023
Q2
$1.19M Buy
917,454
+609,121
+198% +$832K ﹤0.01% 3909
2023
Q1
$543K Buy
308,333
+96,324
+45% +$275K ﹤0.01% 4554
2022
Q4
$666K Sell
212,009
-413,188
-66% -$1.6M ﹤0.01% 4526
2022
Q3
$3.06M Sell
625,197
-581,055
-48% -$2.98M ﹤0.01% 3367
2022
Q2
$4.99M Buy
1,206,252
+515,625
+75% +$2.23M ﹤0.01% 2812
2022
Q1
$4.01M Sell
690,627
-613,227
-47% -$3.65M ﹤0.01% 3167
2021
Q4
$9.78M Buy
1,303,854
+1,104,235
+553% +$9.59M 0.01% 2161
2021
Q3
$1.8M Buy
199,619
+41,768
+26% +$413K ﹤0.01% 4049
2021
Q2
$1.89M Buy
157,851
+41,878
+36% +$474K ﹤0.01% 4028
2021
Q1
$1.45M Sell
115,973
-52,994
-31% -$714K ﹤0.01% 3834
2020
Q4
$2.64M Sell
168,967
-381,765
-69% -$4.47M ﹤0.01% 3011
2020
Q3
$5.2K Buy
+550,732
New +$5.96M 0.01% 1801
2020
Q2
Sell
-1,488,020
Closed -$9.48M 4553
2020
Q1
$9.48M Buy
+1,488,020
New +$11M 0.02% 894
2019
Q2
Sell
-10,882
Closed -$104K 4409
2019
Q1
$104K Buy
+10,882
New +$111K ﹤0.01% 3841
2018
Q4
Sell
-464,840
Closed -$7.88M 4130
2018
Q3
$7.88M Buy
464,840
+447,932
+2,649% +$6.81M 0.01% 1481
2018
Q2
$240K Sell
16,908
-77,756
-82% -$1.29M ﹤0.01% 3499
2018
Q1
$1.8M Sell
94,664
-182,127
-66% -$3.89M ﹤0.01% 2378
2017
Q4
$4.54M Sell
276,791
-665,306
-71% -$9.9M 0.01% 1785
2017
Q3
$14.1M Buy
942,097
+465,953
+98% +$5.15M 0.02% 1004
2017
Q2
$4.19M Buy
476,144
+256,653
+117% +$1.65M 0.01% 1630
2017
Q1
$1.14M Sell
219,491
-14,872
-6% -$59.7K ﹤0.01% 2321
2016
Q4
$715K Sell
234,363
-381,371
-62% -$1.39M ﹤0.01% 2443
2016
Q3
$2.85M Buy
615,734
+80,131
+15% +$408K ﹤0.01% 1706
2016
Q2
$3.1M Buy
535,603
+368,714
+221% +$2.35M 0.01% 1550
2016
Q1
$1.01M Sell
166,889
-1,515,013
-90% -$9.1M ﹤0.01% 2176
2015
Q4
$15.4M Sell
1,681,902
-673,667
-29% -$5.19M 0.03% 682
2015
Q3
$13.3M Buy
2,355,569
+1,589,904
+208% +$13.1M 0.03% 782
2015
Q2
$8.49M Buy
765,665
+21,128
+3% +$272K 0.02% 1077
2015
Q1
$11.7M Buy
744,537
+447,971
+151% +$6.93M 0.02% 933
2014
Q4
$4.51M Sell
296,566
-248,470
-46% -$3.02M 0.01% 1454
2014
Q3
$5.88M Buy
545,036
+362,721
+199% +$4.74M 0.01% 1190
2014
Q2
$2.78M Buy
+182,315
New +$2.62M 0.01% 1563
2013
Q4
Sell
-53,034
Closed -$556K 3739
2013
Q3
$556K Buy
53,034
+33,834
+176% +$336K ﹤0.01% 2472
2013
Q2
$150K Buy
+19,200
New +$168K ﹤0.01% 2821

Other funds holding SGMO

Millennium Management's SGMO Position: Q1 2026 in Review

Millennium Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 37,703 shares — an estimated $15.8K sold.

Millennium Management first reported a position in SGMO in Q2 2013 and held it in 44 quarters. The position peaked at $15.4M in Q4 2015. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Millennium Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 37,703 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $15.8K.
  • Millennium Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 44 quarters.
  • Millennium Management's SANGAMO THERAPEUTICS INC position peaked at $15.4M in Q4 2015.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.